UK markets open in 3 hours 18 minutes

Sangamo Therapeutics, Inc. (SGMO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.5030+0.0100 (+2.03%)
At close: 04:00PM EDT
0.5250 +0.02 (+4.37%)
After hours: 07:17PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 104.37M
Enterprise value 61.47M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.50
Price/book (mrq)1.26
Enterprise value/revenue 0.35
Enterprise value/EBITDA -0.64

Trading information

Stock price history

Beta (5Y monthly) 1.35
52-week change 3-65.99%
S&P500 52-week change 321.08%
52-week high 31.6700
52-week low 30.2900
50-day moving average 30.7870
200-day moving average 30.7150

Share statistics

Avg vol (3-month) 32.44M
Avg vol (10-day) 31.37M
Shares outstanding 5207.5M
Implied shares outstanding 6219.24M
Float 8165.34M
% held by insiders 17.71%
% held by institutions 156.02%
Shares short (15 Apr 2024) 413.25M
Short ratio (15 Apr 2024) 45.95
Short % of float (15 Apr 2024) 46.42%
Short % of shares outstanding (15 Apr 2024) 46.38%
Shares short (prior month 15 Mar 2024) 410.88M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -146.30%
Operating margin (ttm)-2,476.15%

Management effectiveness

Return on assets (ttm)-17.60%
Return on equity (ttm)-136.47%

Income statement

Revenue (ttm)176.23M
Revenue per share (ttm)1.01
Quarterly revenue growth (yoy)-92.50%
Gross profit (ttm)N/A
EBITDA -87.43M
Net income avi to common (ttm)-257.83M
Diluted EPS (ttm)-1.4800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)81M
Total cash per share (mrq)0.45
Total debt (mrq)38.1M
Total debt/equity (mrq)45.97%
Current ratio (mrq)1.98
Book value per share (mrq)0.47

Cash flow statement

Operating cash flow (ttm)-224.84M
Levered free cash flow (ttm)-90.74M